Belysse Group NV (BELYS.BR)
EUR 0.61
(-0.82%)
EUR 0.61
(-0.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 17.48 Million | 27.88 Million | 20.18 Million | 79.59 Million | 49.25 Million | 46.38 Million |
| Net Income | -11.09 Million | -13.28 Million | -16.52 Million | -12.58 Million | 10.4 Million | 7.34 Million |
| Depreciation & Amortization | 19.89 Million | 18.68 Million | 17.14 Million | 40.03 Million | 39.6 Million | 32.43 Million |
| Deferred income taxes | -23.47 Million | 6.76 Million | 3.15 Million | 2.47 Million | -15.05 Million | -6.21 Million |
| Stock-based compensation | 6000.00 | -61 Thousand | 13 Thousand | 34 Thousand | 15 Thousand | 7000.00 |
| Change in working capital | 7.83 Million | -3.87 Million | -11.9 Million | 20.42 Million | -10.85 Million | -13.53 Million |
| Other non-cash items | 24.32 Million | 19.65 Million | 28.29 Million | 29.21 Million | 25.15 Million | 20.14 Million |
| Investing Cash Flow | -11.79 Million | 151.79 Million | -10.96 Million | -26.19 Million | -27.39 Million | -30.82 Million |
| Investments in PPE | -11.79 Million | -11.9 Million | -11.04 Million | -26.23 Million | -29.73 Million | -31.69 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.33 Million | 163.7 Million | 72 Thousand | 43 Thousand | 2.34 Million | 867 Thousand |
| Financing Cash Flow | -7.89 Million | -189.4 Million | -42.67 Million | 36.33 Million | -29.46 Million | -26.04 Million |
| Debt repayment | -7.89 Million | -293.48 Million | -17.94 Million | -53.45 Million | -8.62 Million | -2.13 Million |
| Dividends payments | - | - | - | - | - | -2.87 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.56 Million | 104.08 Million | -24.73 Million | 89.79 Million | -20.84 Million | -21.03 Million |
| Accounts receivables | 979 Thousand | 1.15 Million | -2.41 Million | 5.69 Million | 976 Thousand | -4.49 Million |
| Accounts payables | -9.12 Million | 10.53 Million | 5.53 Million | -2.62 Million | -10.17 Million | 3.05 Million |
| Inventory | 24.45 Million | -14.5 Million | -16.79 Million | 24.1 Million | 156 Thousand | -4.44 Million |
| Other working capital | -8.47 Million | -1.06 Million | 1.78 Million | -6.74 Million | -1.81 Million | -9.09 Million |
| Cash at beginning of period | 38.48 Million | 51.39 Million | 104.44 Million | 19.24 Million | 26.85 Million | 37.33 Million |
| Cash at end of period | 35.81 Million | 38.48 Million | 51.39 Million | 106.28 Million | 19.24 Million | 26.85 Million |
| Capital Expenditure | -11.79 Million | -11.9 Million | -11.04 Million | -26.23 Million | -29.73 Million | -31.69 Million |
| Effect of forex changes on cash | -482 Thousand | 903 Thousand | 1.91 Million | -2.68 Million | - | -1000.00 |
| Net cash flow / Change in cash | -2.67 Million | -12.9 Million | -53.04 Million | 87.04 Million | -7.61 Million | -10.48 Million |
| Free Cash Flow | 5.69 Million | 15.97 Million | 9.13 Million | 53.35 Million | 19.51 Million | 14.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 5.27 Million | 5.27 Million | -11.09 Million | -564 Thousand | -564 Thousand | -4.98 Million |
| Depreciation & Amortization | 4.86 Million | 4.86 Million | 19.89 Million | 5.07 Million | 4.74 Million | 4.87 Million |
| Deferred income taxes | - | - | -23.47 Million | 96 Thousand | - | -19.32 Million |
| Stock-based compensation | 2000.00 | 2000.00 | 6000.00 | 1500.00 | 1500.00 | 1500.00 |
| Change in working capital | -2.47 Million | -2.47 Million | 7.83 Million | 6.47 Million | 6.47 Million | 2 Million |
| Other non-cash items | -943.5 Thousand | -943.5 Thousand | 24.32 Million | 2.18 Million | 2.5 Million | 464 Thousand |
| Investing Cash Flow | -2.56 Million | -2.56 Million | -11.79 Million | -3.06 Million | -3.06 Million | -2.83 Million |
| Investments in PPE | -2.35 Million | -2.35 Million | -11.79 Million | -2.49 Million | -2.49 Million | -2.73 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -205 Thousand | -205 Thousand | -1.33 Million | -564.5 Thousand | -564.5 Thousand | -101.5 Thousand |
| Financing Cash Flow | -7.56 Million | -7.56 Million | -7.89 Million | -5.43 Million | -5.43 Million | -5.29 Million |
| Debt repayment | - | - | -7.89 Million | -4.18 Million | - | -3.71 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -7.56 Million | -7.56 Million | -13.56 Million | -5.43 Million | -5.43 Million | -5.29 Million |
| Accounts receivables | -500.00 | -500.00 | 979 Thousand | 1.84 Million | 1.84 Million | -1.35 Million |
| Accounts payables | - | - | -9.12 Million | -762 Thousand | - | -8.36 Million |
| Inventory | -2.02 Million | -2.02 Million | 24.45 Million | 6.61 Million | 6.61 Million | 5.61 Million |
| Other working capital | -443.5 Thousand | -443.5 Thousand | -8.47 Million | -1.98 Million | -1.98 Million | -2.25 Million |
| Cash at beginning of period | - | - | 38.48 Million | 26.94 Million | - | 38.48 Million |
| Cash at end of period | -3.4 Million | -3.4 Million | 35.81 Million | 35.81 Million | 4.43 Million | 26.94 Million |
| Capital Expenditure | -2.35 Million | -2.35 Million | -11.79 Million | -2.49 Million | -2.49 Million | -2.73 Million |
| Effect of forex changes on cash | - | - | -482 Thousand | -241 Thousand | -241 Thousand | - |
| Net cash flow / Change in cash | -3.4 Million | -3.4 Million | -2.67 Million | 8.87 Million | 4.43 Million | -11.54 Million |
| Free Cash Flow | 4.36 Million | 4.36 Million | 5.69 Million | 10.67 Million | 10.67 Million | -375.5 Thousand |
SHREERAMA
9326
319660
381970
CSOC
ACGX